Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: Findings from the Women and Infants Transmission Study

被引:60
作者
Pitt, J
Brambilla, D
Reichelderfer, P
Landay, A
McIntosh, K
Burns, D
Hillyer, GV
Mendez, H
Fowler, MG
机构
[1] SUNY HLTH SCI CTR,DEPT PEDIAT,BROOKLYN,NY 11203
[2] NEW ENGLAND RES INST,WATERTOWN,MA 02172
[3] RUSH PRESBYTERIAN ST LUKES MED CTR,CHILDRENS HOSP,DEPT IMMUNOL & MICROBIOL,DIV INFECT DIS,BOSTON,MA
[4] HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115
[5] NICHHD,PEDIAT ADOLESCENT & MATERNAL AIDS BRANCH,NIH,BETHESDA,MD 20892
[6] NIAID,DIV AIDS,BETHESDA,MD 20892
[7] UNIV PUERTO RICO,DEPT MICROBIOL,SAN JUAN,PR 00936
关键词
D O I
10.1093/infdis/175.3.567
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Maternal virus load of human immunodeficiency virus 1 (HIV-1) and maternal immunity are both associated with risk of an infected infant. The interrelationship of these two variables in describing that risk was assessed in a multisite study of 475 mother-infant pairs. Infant infection was associated with low CD4 cell percentage, high CD8, CD8/CD38, and CD8/DR cell percentages, persistently positive HIV-1 cultures, and high HIV-1 titer (P <. 001, .001, .005, .006, .001, and .013, respectively). The association of CD4 cell percentage and increased CD8, CD8/CD38, and CD8/DR cell percentages with transmission was restricted to the 42% of women whose HIV-1 cultures were not persistently positive (all P < .001). Women with at least 1 negative culture and high CD4 cell percentage or low CD8 cell percentage were at very low risk (0-4%) of transmitting HIV-1, while those with always positive cultures transmitted at a high rate (18%-27%), regardless of immune status.
引用
收藏
页码:567 / 575
页数:9
相关论文
共 41 条
[1]   A PROSPECTIVE-STUDY OF INFANTS BORN TO WOMEN SEROPOSITIVE FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
BLANCHE, S ;
ROUZIOUX, C ;
MOSCATO, MLG ;
VEBER, F ;
MAYAUX, MJ ;
JACOMET, C ;
TRICOIRE, J ;
DEVILLE, A ;
VIAL, M ;
FIRTION, G ;
DECREPY, A ;
DOUARD, D ;
ROBIN, M ;
COURPOTIN, C ;
CIRARUVIGNERON, N ;
LEDEIST, F ;
GRISCELLI, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (25) :1643-1648
[2]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[3]  
BURCHETT SK, 1996, 3 C RETR OPP INF WAS
[4]  
BURKE DS, 1990, J ACQ IMMUN DEF SYND, V3, P1159
[5]   GUIDELINE FOR FLOW CYTOMETRIC IMMUNOPHENOTYPING - A REPORT FROM THE NATIONAL-INSTITUTE-OF-ALLERGY-AND-INFECTIOUS-DISEASES, DIVISION OF AIDS [J].
CALVELLI, T ;
DENNY, TN ;
PAXTON, H ;
GELMAN, R ;
KAGAN, J .
CYTOMETRY, 1993, 14 (07) :702-715
[6]  
CAO Y, 1995, NEW ENGL J MED, V33, P201
[7]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[8]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[9]   THE NATURAL-HISTORY OF HIV-INFECTION - IMPLICATIONS FOR THE ASSESSMENT OF ANTIRETROVIRAL THERAPY [J].
COREY, L ;
COOMBS, RW .
CLINICAL INFECTIOUS DISEASES, 1993, 16 :S2-S6
[10]   Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission - Effect of maternal zidovudine treatment on viral load [J].
Dickover, RE ;
Garratty, EM ;
Herman, SA ;
Sim, MS ;
Plaeger, S ;
Boyer, PJ ;
Keller, M ;
Deveikis, A ;
Stiehm, ER ;
Bryson, YJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (08) :599-605